Cargando…
Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations
BACKGROUND: In the absence of clinical trial data, large post-marketing observational studies are essential to evaluate the safety and effectiveness of medications during pregnancy. We identified a cohort of pregnancies ending in live birth within the 2000–2007 Medicaid Analytic eXtract (MAX). Herei...
Autores principales: | Palmsten, Kristin, Huybrechts, Krista F., Mogun, Helen, Kowal, Mary K., Williams, Paige L., Michels, Karin B., Setoguchi, Soko, Hernández-Díaz, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693950/ https://www.ncbi.nlm.nih.gov/pubmed/23840692 http://dx.doi.org/10.1371/journal.pone.0067405 |
Ejemplares similares
-
Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset
por: Patorno, Elisabetta, et al.
Publicado: (2020) -
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States
por: Palmsten, Kristin, et al.
Publicado: (2013) -
BlastXtract2: Improving early exploration of (meta) genomes
por: de Weerd, Heleen, et al.
Publicado: (2015) -
XTRACT - Standardised protocols for automated tractography in the human and macaque brain
por: Warrington, Shaun, et al.
Publicado: (2020) -
Association of Neuraxial Labor Analgesia for Vaginal Childbirth With Risk of Autism Spectrum Disorder
por: Straub, Loreen, et al.
Publicado: (2021)